Evidence map›Paper›PMID 36504548›Full record

ArticleHemaSphere2022

The Progress Test of the European Hematology Association: A New Tool for Continuous Learning.

Marielle J Wondergem, Antonio Almeida, Janaki Brolin, Carlos Fernandez de Larrea, Nathalie van Havre, Bas T Hemker, Wietske Hollegien, José-Tomás Navarro, Mahesh Prahladan, Alicia Rovó and 1 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marielle J WondergemDepartment of hematology, Amsterdam University Medical Centers, the Netherlands.
Antonio AlmeidaDepartment of Hematology, Hospital da Luz, Faculdade de Medicina, Universidade Católica Portuguesa, Lisbon, Portugal.
Janaki BrolinDepartment of Internal Medicine, Central Hospital Karlstad, Sweden.
Carlos Fernandez de LarreaDepartment of Hematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Spain.
Nathalie van HavreEducation Department, European Hematology Association, The Hague, the Netherlands.
Bas T HemkerEducational Measurement, Cito, the Netherlands.
Wietske HollegienEducation Department, European Hematology Association, The Hague, the Netherlands.
José-Tomás NavarroDepartment of Hematology, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Spain.
Mahesh PrahladanUniversity of Cambridge, Pathology Portal, Royal college of Pathology, East Suffolk and North Essex Foundation Trust, Suffolk, United Kingdom.
Alicia RovóDepartment of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Switzerland.
Gunnar BirgegårdDepartment of Medical Sciences, Uppsala Unicversity, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36504548
PMCPMC9719893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.